Literature DB >> 8842420

Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture.

A J de Brum-Fernandes1, S Morisset, G Bkaily, C Patry.   

Abstract

1. Prostaglandin E2 (PGE2) is an autacoid that decreases proteoglycan synthesis, increases metalloprotease production by cultured chondrocytes, and can modulate some of the actions of interleukin-1 on cartilage. The objective of the present study was to characterize the subtype of prostaglandin E2 receptor present in bovine chondrocytes in culture. 2. Primary cultures of articular chondrocytes were prepared from slices of bovine carpal cartilage by sequential digestion with type III hyaluronidase, trypsin, type II collagenase, followed by overnight incubation in Dulbecco's Modified Eagle's Medium (DMEM) with type II collagenase, washing, and seeding at a density of 2 x 10(5) cells cm-2 in DMEM with 10% foetal bovine serum. 3. PGE2 and carbaprostacyclin induced dose-dependent increases in intracellular cyclic AMP in bovine chondrocytes in culture. The potencies of these compounds were different, and maximal doses of PGE2 and carbaprostacyclin had an additive effect. PGD2 induced a small increase in intracellular cyclic AMP only at a high concentration (10(-5) M). 4. PGE2 was more potent that the EP2 agonist 11-deoxy-PGE1 at inducing increases in intracellular cyclic AMP. The EP2 agonist butaprost, however, induced only a small increase at a concentration of 10(-5)M. 17-Phenyl-PGE2 (EP1 agonist), sulprostone and MB 28767 (15S-hydroxy-9-oxo-16-phenoxy-omega-tetranorprost-13E-enoic acid) (EP3 agonists) did not induce an increase in intracellular cyclic AMP at concentrations up to 10(-5)M. 5. The EP4 antagonist AH 23848B ([1 alpha(Z),2 beta, 5 alpha]-(+/-) -7-[5-[[(1,1'-biphenyl)-4-yl]methoxyl-2-(4-morpholinyl) -3-oxocyclopentyl]-5-heptenoic acid) antagonized PGE2 but not carbaprostacyclin effects on intracellular cyclic AMP. The Schild plot slope was different from 1 but this could be due to an interaction of PGE2 with IP receptors in high doses. The exact nature of the antagonism by compound AH 23848B could not be definitely established in these experimental conditions. 6. Neither PGE2 nor any of its analogues inhibited the increase in intracellular cyclic AMP induced by forskolin, and pertussis toxin did not alter the response to PGE2, suggesting that no Gi-coupled PGE2 receptors are present in these cells. Stimulation with PGE2 did not induce significant increases in intracellular inositol-trisphosphate levels nor increases in intracellular free calcium as determined by confocal microscopy, suggesting the absence of phospholipase-C-coupled or of calcium channel-coupled PGE2 receptors in bovine chondrocytes in these experimental conditions. 7. These results show for the first time that bovine chondrocytes in culture present a functional PGE2 receptor that has some pharmacological characteristics of an EP4 subtype, as well as an IP receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842420      PMCID: PMC1909846          DOI: 10.1111/j.1476-5381.1996.tb15580.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degradation: protective effect of NSAID.

Authors:  J P Pelletier; J Martel-Pelletier
Journal:  J Rheumatol Suppl       Date:  1989-08

2.  Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells.

Authors:  D L Burns; E L Hewlett; J Moss; M Vaughan
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

3.  Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin.

Authors:  J Pless; W Bauer; U Briner; W Doepfner; P Marbach; R Maurer; T J Petcher; J C Reubi; J Vonderscher
Journal:  Scand J Gastroenterol Suppl       Date:  1986

4.  The phosphatidylinositol response of chondrocytes in culture.

Authors:  V M Baragi; D T Dudley; D J Schrier
Journal:  Agents Actions       Date:  1989-06

5.  Implication of phospholipase C in the steroidogenic action of angiotensin II.

Authors:  G Boulay; N Gallo-Payet; G Guillemette
Journal:  Eur J Pharmacol       Date:  1990-10-30       Impact factor: 4.432

6.  Prejunctional inhibitory effects of prostanoids on sympathetic neurotransmission in the rabbit iris-ciliary body.

Authors:  S E Ohia; J E Jumblatt
Journal:  J Pharmacol Exp Ther       Date:  1990-10       Impact factor: 4.030

7.  Evaluation of ZK110841 and AH6809, an agonist and an antagonist of prostaglandin DP-receptors on human platelets, with a PGD2-responsive cell line from bovine embryonic trachea.

Authors:  S Ito; E Okuda; K Sugama; M Negishi; O Hayaishi
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

8.  Leukotriene B4 and prostaglandin E2-like activity in synovial fluid in osteoarthritis.

Authors:  O Sahap Atik
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1990-04       Impact factor: 4.006

9.  Phospholipase A2 activity in human osteoarthritic cartilage.

Authors:  E Vignon; P Mathieu; P Louisot; J Vilamitjana; M F Harmand; M Richard
Journal:  J Rheumatol Suppl       Date:  1989-08

10.  Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

Authors:  R R Gorman; S Bunting; O V Miller
Journal:  Prostaglandins       Date:  1977-03
View more
  7 in total

1.  cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21Cip1, and PCNA.

Authors:  Soheil Naderi; Jean Y J Wang; Tung-Ti Chen; Kristine B Gutzkow; Heidi K Blomhoff
Journal:  Mol Biol Cell       Date:  2005-01-12       Impact factor: 4.138

Review 2.  Role of G-proteins in the differentiation of epiphyseal chondrocytes.

Authors:  Andrei S Chagin; Henry M Kronenberg
Journal:  J Mol Endocrinol       Date:  2014-06-30       Impact factor: 5.098

3.  Prostaglandin E(2) increases cyclic AMP and inhibits endothelin-1 production/secretion by guinea-pig tracheal epithelial cells through EP(4) receptors.

Authors:  S Pelletier; J Dubé; A Villeneuve; F Gobeil; Q Yang; B Battistini; G Guillemette; P Sirois
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

4.  The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis.

Authors:  Jennifer M McCoy; Joan R Wicks; Laurent P Audoly
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

5.  Prostaglandin E2 receptors EP1 and EP4 are up-regulated in rabbit chondrocytes by IL-1beta, but not by TNFalpha.

Authors:  M Angeles Alvarez-Soria; Raquel Largo; Olga Sanchez-Pernaute; Emilio Calvo; Jesús Egido; Gabriel Herrero-Beaumont
Journal:  Rheumatol Int       Date:  2007-03-31       Impact factor: 3.580

6.  Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ--prostaglandin E2 dependent proliferation of growth plate chondrocytes.

Authors:  Christoph Brochhausen; Pia Neuland; C James Kirkpatrick; Rolf M Nüsing; Günter Klaus
Journal:  Arthritis Res Ther       Date:  2006-04-28       Impact factor: 5.156

7.  Induction of nerve growth factor expression and release by mechanical and inflammatory stimuli in chondrocytes: possible involvement in osteoarthritis pain.

Authors:  Emilie Pecchi; Sabrina Priam; Marjolaine Gosset; Audrey Pigenet; Laure Sudre; Marie-Charlotte Laiguillon; Francis Berenbaum; Xavier Houard
Journal:  Arthritis Res Ther       Date:  2014-01-20       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.